Showing results (851-860 of 22,083) with videos related to
Sort By:
Pageof 2,209
Oncogene|June 9, 2004
MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMROwen J Sansom, Stefan M Bishop, Adrian Bird, et al.Oncogene|June 9, 2004
Disruption of the Rad9/Rad1/Hus1 (9-1-1) complex leads to checkpoint signaling and replication defectsShilai Bao, Tao Lu, Xin Wang, et al.Oncogene|June 9, 2004
Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cellsFred Penninkhof, J Anton Grootegoed, Leen J BlokOncogene|June 9, 2004
Selective inhibition of STAT3 induces apoptosis and G(1) cell cycle arrest in ALK-positive anaplastic large cell lymphomaHesham M Amin, Timothy J McDonnell, Yupo Ma, et al.Oncogene|June 23, 2004
Mechanisms underlying differential expression of interleukin-8 in breast cancer cellsAriane Freund, Valérie Jolivel, Sébastien Durand, et al.Oncogene|June 23, 2004
Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomasVassiliki Theodorou, Mandy Boer, Britta Weigelt, et al.Oncogene|June 23, 2004
L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathwayKrishna P Sarker, Ki-Young LeeOncogene|June 23, 2004
Involvement of c-Src kinase in the regulation of TGF-beta1-induced apoptosisSeok Soon Park, Young-Woo Eom, Eun Hee Kim, et al.Oncogene|June 23, 2004
p53-dependent transcription can exhibit both on/off and graded response after genotoxic stressArvi Jõers, Viljar Jaks, Johanna Kase, et al.Oncogene|June 23, 2004
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growthDeborah A Altomare, Hui Qin Wang, Kristine L Skele, et al.Pageof 2,209